Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck

NARecruitingINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

October 25, 2021

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Squamous Cell CarcinomaNonmelanoma Skin CancerCutaneous Squamous Cell Carcinoma
Interventions
PROCEDURE

sentinel lymph node biopsy (SLNB)

"Preoperative Lymphoscintigraphy: A standard injection of 2 mCi of 99m-Technetium sulfur colloid. Sequential immediate and delayed images will be obtained using SPECT/CT using a gamma probe. Ten-second counts will be done in areas of high activity to identify location of sentinel lymph node (SLN). After removal of the lymph node, a 10-second count will be done of the lymph node ex-vivo followed by 10-second count of the lymph node resection bed to ensure removal of SLN (less than 10% activity of LN).~Surgical resection: Mohs micrographic surgery followed by SLNB. Intraoperative margins around the tumor will be confirmed through frozen section analysis. Patients with planned free flap reconstruction, will undergo SLNB with intraoperative, frozen section analysis. If lymph node is positive, immediate completion neck dissection will occur."

Trial Locations (1)

46202

RECRUITING

Indiana University Melvin & Bren Simon Cancer Center, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER